FDA
approval
· 2025-08-05
FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Biocon Pharma Inc.)
Summary
FDA approved Biocon Pharma Inc.'s supplemental application for pravastatin sodium, authorizing continued marketing of the product as a statin-indicated therapy …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)